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Abstract Light absorption photometry of HepG2 cells treated
with phenobarbital for enhancing the content of cytochrome P-
450 and the synthesis of erythropoietin revealed an influence on
all cytochromes detectable in the wavelength range between 400
and 620 nm. No correlation was found between specific changes
of cytochrome P-450 absorption and increased EPO synthesis as
proposed earlier by Fandrey et al. (Life Sci. (1990) 47, 127^134).
In the present study, however, the increased erythropoietin
synthesis could be related to a decreased intracellular hydroxyl
radical level described as crucial for the oxygen regulated gene
expression (Kietzmann et al., Biochem. J. (1998) 335, 425^432;
Porwol et al., Eur. J. Biochem. (1998) 256, 16^23).
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1. Introduction
One possible signal cascade leading to oxygen dependent
erythropoietin (EPO) gene expression [2] might involve a cy-
tochrome [4] which produces H2O2 as a function of the oxy-
gen partial pressure (PO2) [5]. H2O2 may be degraded to hy-
droxyl radical (cOH) by a perinuclear Fenton reaction [6]
which in£uences transcription factors regulating EPO gene
expression [7]. As the oxygen sensing cytochrome Goºrlach et
al. [4,8] and Ehleben et al. [6] proposed a low output NADPH
oxidase. Similarities in light absorption spectra, subunit com-
position and the capacity for reactive oxygen species (ROS)
production makes it likely that the oxygen sensor cytochrome
is an isoenzyme of the high output NADPH oxidase of neu-
trophils. Fandrey et al. [1], however, proposed that the cyto-
chrome P-450 monooxygenase might be a possible candidate
for the oxygen sensing protein in HepG2 cells. The activity of
cytochrome P-450 requires NADPH and molecular oxygen
with a half-saturation at a PO2 of 20^100 Torr [9]. HepG2
cells exposed to phenobarbital to enhance the cytochrome P-
450 content, responded with an increased EPO synthesis. EPO
synthesis was blunted by diethyldithiocarbamate probably by
inhibiting the cytochrome P-450 reductase. Cytochrome P-450
has been proposed as microvascular oxygen sensor as well due
to the regulatory function of various cytochrome P-450 me-
tabolites of arachidonic acid in£uencing vascular tone primar-
ily by a¡ecting K channel activity [10].
The question was therefore addressed whether light absorp-
tion spectral analysis as described by Ehleben et al. [6] and
Porwol et al. [3] is able to detect speci¢c upregulation of the
cytochrome P-450 system in HepG2 cells exposed to pheno-
barbital. Furthermore the intracellular level of cOH was de-
termined to see whether enhanced EPO synthesis after pheno-
barbital treatment was due to decreased levels of the radical.
We found that cytochromes other than cytochrome P-450
showed higher absorption changes after exposure to pheno-
barbital for 72 h. This may indicate either an enhanced cyto-
chrome synthesis and/or changes in the redox state. Because
no obvious change in absorption of a single cytochrome was
evident the identi¢cation of the primary oxygen sensor cyto-
chrome by spectrophotometrical analysis after phenobarbital
application appears to be impossible. However, we found sig-
ni¢cantly decreased intracellular cOH level after 72 h pheno-
barbital exposure which were accompanied by enhanced EPO
production. Since the control of intracellular cOH levels has
been shown to be critical for EPO gene expression [7] the
reduced level of the cOH radical may explain increased EPO
production.
2. Materials and methods
2.1. Tissue culture
HepG2 cells (ATCC HB 8065) were cultivated in monolayer and
spheroid tissue culture as described by Goºrlach et al. [4] in RPMI
1640 medium (Life Technologies, Eggenstein-Leopoldshafen, Ger-
many) supplemented with 2 mM L-glutamine, 10% fetal calf serum,
penicillin (100 U/ml) and streptomycin (100 Wg/ml) at 37‡C in an
incubator containing 5% CO2 in humidi¢ed air (Stericult 200, Labo-
tect, Goºttingen, Germany). Spheroid cultures were started with
2.5U105 cells in agarose treated petri dishes (Life Technologies)
with 130 ml medium. After reaching a diameter of 150 Wm spheroids
were transferred into siliconized cylindrical spinner £asks (11 cm di-
ameter and 24 cm high). Spin rate was set at 40 rpm of the 250 ml
medium which was replenished twice a week. For phenobarbital
(Merck, Darmstadt, Germany) treatment the drug was added to the
spheroids (diameter between 700 and 800 Wm) kept in petri dishes at a
concentration of 1.5 mM 72 h prior to the experiments. Control
spheroids were kept in petri dishes for the same time. During the
absorption measurements the solutions used contained no phenobar-
bital [1].
2.2. Light absorption photometry
Spheroids were located in a superfusion chamber on a small opaque
bench with little holes of the same diameter as the spheroids. The
superfusion chamber has been described in detail before [4,8]. Brie£y
isotonic salt solution (Locke’s solution) containing glucose (5 mM)
was equilibrated with di¡erent O2/CO2 mixtures in order to adjust the
desired PO2 at pH 7.42. The £ow rate through the chamber was 30 ml
per minute. Spheroids were supplied symmetrically with nutrients by
this procedure. The temperature was maintained at 36‡C. Oxygen
tension, pH and temperature in the Locke’s solution were controlled
by corresponding probes. For light absorption measurements, the
superfusion chamber was mounted on the stage of a light microscope
(Olympus, Hamburg, Germany). White light from a halogen bulb (12
V, 100 W) transilluminating the spheroid only passed to the objective
(40U). Absorption changes at di¡erent wavelengths were recorded by
a photodiode-array spectrophotometer (MCS 210, Zeiss, Cologne,
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Germany) connected to the third ocular of the microscope trinocular
head via a light guide. Di¡erence spectra were calculated by automati-
cally subtracting the absorbance recorded under conditions of 20%
O2, 3% CO2 and 77% N2 (aerobic steady state) from the spectra under
conditions of 3% CO2 and 97% N2 or 97% CO (N2/CO steady state).
Di¡erence spectra were subsequently analysed and plotted using the
software package TechPlot (Dr. Dittrich, Braunschweig, Germany).
2.3. Reactive oxygen species
For measuring intracellular ROS levels after three days of pheno-
barbital (1.5 mM) treatment HepG2 cells cultured in 96 multi-well
plates were stained with dihydrorhodamine 123 (25 WM; Molecular
Probes, Eugene, OR, USA) for half an hour [4]. Dihydrorhodamine
123 is a non-£uorescent dye described to speci¢cally detect H2O2
(Molecular Probes). The reaction with H2O2, however, is rather
slow under ambient conditions. It has been shown by Ehleben et al.
[6] and Porwol et al. [3] that the intracellular conversion of non-£uo-
rescent dihydrorhodamine 123 to £uorescent rhodamine 123 in the
presence of H2O2 is due to a reaction with cOH generated by a peri-
nuclearly located iron mediated Fenton reaction. Thirty minutes after
carefully washing each well with PBS intracellular rhodamine 123
£uorescence intensity was measured using a multi-well scanning £uo-
rescence photometer (Titertek, Fluoreskan II, Flow, Meckenheim,
Germany). Forty-eight wells were recorded in each experiment.
2.4. Metabolic activity
Metabolic activity was determined by the commercially available
MTT assay (Cell proliferation Kit I (MTT), Boehringer Mannheim,
Germany). The assay is based on the cleavage of the tetrazolium salt
MTT, in the presence of an electron coupling reagent, i.e. succinate
tetrazolium reduction by active mitochondria. HepG2 cells were cul-
tured in the presence of phenobarbital (1.5 mM) for three days in a
96-well tissue culture plate (Falcon) at 37‡C at a starting cell density
of 0.5U105 cells per well. Cells were then incubated with the MTT
solution for 4 h when the water-insoluble formazan dye is formed.
After solubilization, the formazan dye was quantitated by measuring
absorbance at 540 nm using a scanning multi-well spectrophotometer
(MR5000, Dynatech, Denkendorf, Germany).
2.5. Erythropoietin mRNA measurements
HepG2 spheroids treated with phenobarbital for three days were
washed with PBS after removal of the spent cell culture medium and
lysed with 700 Wl of guanidinium thiocyanate (4 M with 0.1 M L-
mercaptoethanol). Total RNA was extracted by the acid-phenol meth-
od [11]. After dissolving the RNA in diethylpyrocarbonate treated
water the concentration was determined by measuring the absorbance
at 260 nm. One Wg of total RNA was reversed transcribed into ¢rst
strand cDNA using oligo-dT15 as primer for the reverse transcriptase
M-MLV RT-superscript (Gibco Life Technologies) in a total volume
of 25 Wl. Reverse transcription was performed at 42‡C for 60 min after
an initial denaturation step at 68‡C for 10 min. The reaction was
terminated by boiling the samples for 10 min. Until quantitation by
a competitive PCR cDNA stocks were kept at 320‡C. Competitive
PCR for EPO mRNA was performed exactly as described [12]. Re-
sults of the quantitative PCR are expressed in amol/Wg of total RNA.
2.6. Statistical analysis
Data are presented as mean þ standard deviations. For statistical
analysis the Student’s t-test was performed. Di¡erences were consid-
ered signi¢cant when the P-value was 6 0.05.
3. Results
3.1. Light absorption spectra
Fig. 1a shows the mean value of N2 minus aerobic steady
state di¡erence spectra (dotted line) of 9 single untreated
HepG2 spheroids. In the wavelength range between 400 nm
and 620 nm characteristic K, L and Q absorbance peaks of the
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Fig. 1. Light absorption photometry (X-axis = wavelength in nm, Y-axis = optical density in arbitrary units). a: Dotted line: mean value of 9 N2
minus aerobic steady state light absorption di¡erence spectra recorded in the wavelength range between 400 nm and 620 nm on HepG2 spher-
oids under control conditions. Full line: mean value of 9 N2 minus aerobic steady state light absorption di¡erence spectra recorded in the
same wavelength range on HepG2 spheroids after treatment with 1.5 mM phenobarbital for 72 h. b: Dotted line: mean value of 9 CO minus
aerobic steady state light absorption di¡erence spectra recorded in the wavelength range between 400 nm and 620 nm on HepG2 spheroids
under control conditions. Full line: mean value of 9 CO minus aerobic steady state light absorption di¡erence spectra recorded in the wave-
length range between 400 nm and 620 nm on HepG2 spheroids after treatment with 1.5 mM phenobarbital for 72 h.
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di¡erent cytochromes contributing to the spectrum can be
identi¢ed: peaks are for cytochrome c at 550, 520 and 420
nm, cytochrome aa3 at 602, 520 and 445 nm or cytochrome b
at 560, 530 and 430 nm [13,14]. Deconvolution of these di¡er-
ence spectra revealed ^ beside the mitochondrial cytochromes
^ a non-mitochondrial cytochrome b558 peaking at 558 nm
[3,6]. Furthermore, the broad shoulder between 440 and 455
nm suggests the contribution of cytochrome P-450. The full
line in Fig. 1a represents the mean value of N2 minus aerobic
steady state di¡erence spectra of 9 single HepG2 spheroids
exposed to 1.5 mM phenobarbital for 72 h. Light absorbance
at all characteristic cytochrome peaks as described above was
about doubled compared to control conditions without a sig-
ni¢cant shift in the peaks of the absorption maxima with
respect to the wavelength. No speci¢c single cytochrome could
be identi¢ed as being speci¢cally a¡ected by phenobarbital
treatment.
Fig. 1b shows the mean value of CO minus aerobic steady
state di¡erence spectra of the 9 control HepG2 spheroids
(dotted line) as well as of the same 9 HepG2 spheroids treated
with 1.5 mM phenobarbital for 72 h. Due to the speci¢c CO
a⁄nity of cytochrome P-450 [15] the characteristic light ab-
sorption peak at 450 nm is prominent particularly after phe-
nobarbital treatment (full line). The anoxic situation of the
spheroid tissue due to superfusion with 97% CO-equilibrated
medium leads to a reduction of the mitochondrial and non-
mitochondrial cytochromes (see characteristic peaks at 520,
550 and 602 nm and the shoulder at 560 nm).
3.2. ROS formation and metabolic activity
Phenobarbital treatment caused a signi¢cant decrease of the
intracellular cOH level in HepG2 cells when measured with the
dihydrorhodamine 123 technique (Fig. 2a). Metabolic activity,
determined with the MTT assay, increased in phenobarbital
treated HepG2 cells (Fig. 2b). A higher mitochondrial mass or
a change in the mitochondrial redox state as one may assume
from the light absorption measurements (Fig. 1) could be
responsible for this e¡ect. The higher metabolic activity ex-
cludes toxic e¡ects of phenobarbital on HepG2 cells.
3.3. EPO production
HepG2 spheroids with a diameter between 700 and 800 Wm
were treated in 2 experiments with 1.5 mM phenobarbital for
72 h. Each experiment includes about 20^30 spheroids. EPO
mRNA increases from 116 amol/Wg total RNA under control
conditions to 174 amol/Wg total RNA under phenobarbital
treatment. These results indicate that HepG2 cells in multi-
cellular spheroid culture as they were used for photometric
studies respond to phenobarbital treatment with an increased
EPO production as described by Fandrey et al. [1] for HepG2
cells in monolayer culture.
4. Discussion
Our experiments con¢rm earlier results [1] that phenobarbi-
tal enhances hypoxia-induced EPO synthesis in HepG2 cells.
CO versus aerobic steady state di¡erence spectra revealed an
enhanced absorption peak at 450 nm most probably caused
by an increased content of the Fe2 form of cytochrome P-450
due to phenobarbital exposure [15]. Interestingly, phenobarbi-
tal also induced higher absorption peaks at wavelengths typ-
ical for mitochondrial and non-mitochondrial cytochromes. In
line with these ¢ndings is the enhanced succinate tetrazolium
reduction by mitochondria as found in the MTT assay. How-
ever, our spectral analysis does not allow to distinguish
whether the concentration or the redox state, i.e. the activity
state of the mitochondria were changed by phenobarbital
treatment. This general in£uence of phenobarbital on cyto-
chromes in HepG2 cells impedes the identi¢cation of a single
heme protein as part of the primary oxygen sensor.
Di¡erent mitochondrial and non-mitochondrial proteins
have been proposed as potential cellular oxygen sensors.
The rat mitochondrial outer membrane-bound benzodiazepine
receptor (MBR) is involved in steroidogenesis, heme biosyn-
thesis, cell growth and di¡erentiation, control of mitochon-
drial respiration, and immune and stress response. When
MBR was expressed in wild-type and TspO(3) (tryptophan-
rich sensory protein) strains of the facultative photohetero-
troph bacterium Rhodobacter sphaeroides, MBR substitutes
for TspO and inhibits ^ in response to oxygen ^ the expression
of genes necessary for photosynthesis. Thus MBR was pro-
posed to act as a mitochondrial oxygen sensor [16]. In isolated
perfused cat carotid bodies CO competed with O2 in oxygen
sensing. The action spectrum of the photochemical response
was characteristic of the CO bound to mitochondrial cyto-
chrome a3 suggesting that this cytochrome acts as a possible
oxygen sensor [17]. Poisoning the respiratory chain, however,
does not a¡ect the O2-dependent activation of hypoxia induc-
ible factor 1 (HIF-1), the principal transcription factor com-
plex in control of the hypoxia induced expression of the genes
encoding erythropoietin, glycolytic enzymes and vascular en-
dothelial growth factor [18]. Therefore, it is likely that a non-
mitochondrial heme proteins acts as an oxygen sensor. A can-
didate is a low output NAD(P)H oxidase closely related to or
even an isoenzyme of the respiratory burst (high output)
NADPH oxidase of neutrophils [4,8]. This low output
NAD(P)H oxidase was proposed to be responsible for the
oxygen-dependent generation of H2O2, the putative intracel-
lular messenger between the sensor and the transcriptional
apparatus [5]. Components of such an oxidase could be local-
ized immunohistochemically in the cell membrane of HepG2
cells [6]. This notion is supported by the e¡ect of diphenylene
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Fig. 2. Hydroxyl radical generation and metabolic activity (Y-axis =
arbitrary units, P = signi¢cance level). a: Intracellular cOH level of
HepG2 cells under control conditions and after treatment with 1.5
mM phenobarbital for 72 h. b: Metabolic activity (MTT-test) of
HepG2 cells under control conditions and after treatment with 1.5
mM phenobarbital for 72 h.
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iodonium (DPI), a typical inhibitor of the NADPH oxidase,
tested on ¢ve genes which show oxygen-regulated expression:
erythropoietin, vascular endothelial growth factor, lactate de-
hydrogenase-A, glucose transporter-1 and placental growth
factor. For each gene, the response to hypoxia was speci¢cally
inhibited by low doses of DPI [19]. However, DPI inhibition
of the NADPH oxidase did not mimic the hypoxic response,
i.e. DPI did not enhance the expression of the above men-
tioned oxygen regulated genes under conditions of a high
PO2. We therefore hypothesize that hypoxia does not impair
the electron £ux through the oxidase. The observed decrease
of H2O2 production in HepG2 cells [5] under hypoxia is most
likely due to a decreased number of oxygen molecules avail-
able for reduction by the oxidase.
In addition, other oxygen sensing tissues seem to have a low
output NAD(P)H oxidase as part of oxygen sensor. Mohaz-
zab et al. [20] as well as Grimminger et al. [21] characterized ^
predominantly by means of DPI ^ an NAD(P)H oxidoreduc-
tase that was claimed to be involved in hypoxia sensing and
speci¢c signal transduction events underlying hypoxic pulmo-
nary vasoconstriction. Fluorescence immunocytochemistry
and light absorption photometry of rat lung slices revealed
the presence of a unique cytochrome b245 containing
NAD(P)H-oxidase protein in the walls of pulmonary arteries.
It was concluded that this system may be involved in the
initiation of hypoxic pulmonary vasoconstriction by a DPI-
sensitive release of superoxide under hypoxic conditions [22].
Pulmonary neuroepithelial body cells (NEB) operating as
chemoreceptors in airways and NEB-related tumors co-ex-
press mRNAs for both the hydrogen peroxide sensitive volt-
age gated potassium channel subunit KV3.3a and membrane
components of NADPH oxidase [21]. Moreover, in chemo-
receptor type I cells of the carotid body di¡erent components
of the NADPH oxidase like p22phox, gp91phox, p47phox and
p67phox [22^25] are colocalized and may act as an oxygen
sensor protein complex in control of ion channel activity
and gene expression by O2-dependent oxygen radical produc-
tion [26,27]. However, wild-type B-cell lines as well as cyto-
chrome b558(3) chronic granulomatous disease-derived B-cell
lines, de¢cient in either p22phox or gp91phox of the high output
NADPH oxidase, showed no impairment with respect to hy-
poxia- or CoCl2-induced expression of VEGF and aldolase A
[28]. This does not necessarily contradict a low output
NAD(P)H oxidase as part of the actual oxygen sensor since
it is not clear whether the low output oxidase is also a¡ected
by the mutations that lead to the disease with a loss of func-
tion of the high output oxidase in the B-cells used by Wenger
et al. [28].
We found a signi¢cant decrease in the intracellular cOH
level of HepG2 cells after phenobarbital exposure. This might
have been caused by a reduced ROS production rate by the
di¡erent cytochromes or an altered Fenton reaction due to
changes in Fe2/Fe3 availability. Decreased cOH level after
phenobarbital treatment would then be responsible for the
enhanced EPO synthesis without directly a¡ecting an oxygen
sensing cytochrome. Hydrogen peroxide (H2O2) detected in
EPO-producing HepG2 cells [4] depressed the hypoxia stimu-
lated EPO production [5]. The inhibition was antagonized by
iron chelators and the cOH scavengers dimethylthiourea or
tetramethylthiourea [7] indicating the involvement of a Fen-
ton-type reaction. Such a reaction was visualized in the peri-
nuclear space of HepG2 cells [3,6]. Likewise, in primary rat
hepatocytes H2O2 inhibited the insulin dependent expression
of glucokinase mRNA induced by a low PO2 and restored
glucagon dependent phosphoenolpyruvate carboxykinase
mRNA expression that was reduced under venous PO2 in a
perinuclear Fenton reaction [2,29].
On the molecular level the e¡ects of H2O2 on EPO produc-
tion have been attributed to an increase in the transcription
factor hGATA2, which acts as an repressor in the EPO pro-
moter in Hep3B cells [30]. In addition, H2O2 is described to
a¡ect the redox sensitive EPO mRNA binding protein [31]
and to decrease the stability of hypoxia-inducible factor 1K
protein (HIF-1K) [32]. HIF-1K and HIF-1L are essential com-
ponents of the heterodimeric transcription factor HIF-1. HIF-
1, the key regulator in the expression of PO2 dependent genes,
contains a 2Fe2-cluster probably involved in the above de-
scribed Fenton reaction [33].
Whereas the importance of ROS as second messengers for
PO2-dependent gene expression seems to ¢nd support from
several groups working on the oxygen sensing ¢eld the iden-
ti¢cation of the primary oxygen sensing cytochrome produc-
ing in dependence of PO2 ROS remains di⁄cult.
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